Clinical trials
Recruiting Leukemia, Myelomonocytic, Chronic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 10 |
| Fred Hutchinson Cancer Center | 7 |
| Mayo Clinic | 3 |
| City of Hope Medical Center | 2 |
| Aptose Biosciences Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Cogent Biosciences, Inc. | 1 |
| Crossbow Therapeutics, Inc. | 1 |
| Douglas Tremblay | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 44 |
| Leukemia, Myeloid, Acute | 27 |
| Myelodysplastic Syndromes | 24 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia, Biphenotypic, Acute | 10 |
| Primary Myelofibrosis | 9 |
| Anemia, Refractory, with Excess of Blasts | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 |
| Myeloproliferative Disorders | 7 |
| Hodgkin Disease | 6 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.